Hendershot Investments’s Edwards Lifesciences EW Stock Holding History

Hendershot Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,929	Closed	-$150K	–	126
2025 Q3	$150K	Hold	1,929	–	–	0.02%	125
2025 Q2	$151K	Hold	1,929	–	–	0.02%	128
2025 Q1	$140K	Hold	1,929	–	–	0.02%	128
2024 Q4	$143K	Hold	1,929	–	–	0.02%	130
2024 Q3	$127K	Hold	1,929	–	–	0.02%	129
2024 Q2	$178K	Sell	1,929 -171	-8%	-$15.1K	0.03%	120
2024 Q1	$201K	Hold	2,100	–	–	0.03%	119
2023 Q4	$160K	Hold	2,100	–	–	0.02%	128
2023 Q3	$145K	Hold	2,100	–	–	0.02%	131
2023 Q2	$198K	Hold	2,100	–	–	0.03%	124
2023 Q1	$174K	Hold	2,100	–	–	0.03%	133
2022 Q4	$157K	Hold	2,100	–	–	0.03%	137
2022 Q3	$174K	Hold	2,100	–	–	0.03%	127
2022 Q2	$200K	Hold	2,100	–	–	0.04%	126
2022 Q1	$247K	Hold	2,100	–	–	0.04%	127
2021 Q4	$272K	Buy	+2,100	New	+$245K	0.04%	124

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Hendershot Investments's EW Position: Q4 2025 in Review

Hendershot Investments sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 1,929 shares — an estimated $150K sold.

Hendershot Investments first reported a position in EW in Q4 2021 and held it in 16 quarters. The position peaked at $272K in Q4 2021. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

Hendershot Investments reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
Hendershot Investments sold 1,929 Edwards Lifesciences shares in Q4 2025, an estimated $150K.
Hendershot Investments first reported a position in Edwards Lifesciences in Q4 2021 and held it in 16 quarters.
Hendershot Investments's Edwards Lifesciences position peaked at $272K in Q4 2021.
1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Hendershot Investments's 13F filing for Q4 2025, filed 26 Jan 2026.